NCT05686148

Brief Summary

This study was needed to relieve the pain associated with subcutaneous injection, which is an application performed by nurses, to increase patient satisfaction, to increase patient compliance with treatment, and to strengthen positive patient-nurse communication. The purpose of this study is to assess the effect of vibration stimulation application on subcutan injection induced pain and patient satisfaction. The study will be carried out in the internal medicine service of a university hospital. Vibration will be applied during subcutaneous injection of anticoagulant to one group, but not to the other group. It was planned to include 85 patients in the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2022

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 17, 2023

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
Last Updated

January 17, 2023

Status Verified

January 1, 2023

Enrollment Period

4 months

First QC Date

December 30, 2022

Last Update Submit

January 8, 2023

Conditions

Keywords

Acute PainPersonal SatisfactionInjections, Subcutaneous

Outcome Measures

Primary Outcomes (5)

  • Patient Information Form

    It includes some socio-demographic characteristics of the individual (age, gender, place of residence, marital status, educational status, employment status).

    day 1

  • Visual Analog Scale

    Scale, 10 cm long, horizontal or vertical; It consists of a line starting with "No Pain" and ending with "Unbearable Pain". The use of VAS should be explained to the patient very well. The patient is asked to indicate the severity of the pain with a sign on this line where he deems appropriate. The distance between the onset of no pain and this point is measured in cm and recorded. Values range from 0 to 10, and patients' pain levels are evaluated over 10 points as 0 = no pain, 10 = unbearable pain.

    day 1

  • Visual Analog Scale

    Scale, 10 cm long, horizontal or vertical; It consists of a line starting with "No Pain" and ending with "Unbearable Pain". The use of VAS should be explained to the patient very well. The patient is asked to indicate the severity of the pain with a sign on this line where he deems appropriate. The distance between the onset of no pain and this point is measured in cm and recorded. Values range from 0 to 10, and patients' pain levels are evaluated over 10 points as 0 = no pain, 10 = unbearable pain.

    day 2

  • Visual Patient Satisfaction Scale

    The visual patient satisfaction scale combines with the features of the well-known VAS (Visual Analogue Scale). It consists of a 100 mm horizontal line without numbers. At one end of the line is the phrase "I am not satisfied at all" and at the other end is the statement "Very satisfied". The patient must synthesize all the components that affect him in relation to the medical care given, determine the state of satisfaction he is in and find the point on the line that corresponds to his situation.

    day 1

  • Visual Patient Satisfaction Scale

    The visual patient satisfaction scale combines with the features of the well-known VAS (Visual Analogue Scale). It consists of a 100 mm horizontal line without numbers. At one end of the line is the phrase "I am not satisfied at all" and at the other end is the statement "Very satisfied". The patient must synthesize all the components that affect him in relation to the medical care given, determine the state of satisfaction he is in and find the point on the line that corresponds to his situation.

    day 2

Study Arms (2)

Intervention

EXPERIMENTAL

Vibration will be applied to the injection site for 5 minutes before the procedure.

Other: Vibration

Control

NO INTERVENTION

No application will be made

Interventions

The device used for vibration application is produced to control pain and direct attention by providing 6000/min vibration. According to Melzack and Wall's Gate Control Theory, the application of local vibration reduces perceived pain by stimulating nerve fibers. Therefore, it should be ensured that the device is in full contact with the skin. The device can be used again by wiping with 70% alcohol. The device is placed 3 cm above the area to be injected. Vibration is applied to the area for 5 minutes before the procedure.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteers aged 18 and over,
  • are conscious and have no communication problems,
  • body mass index (BMI) of 18.5 to 30kg/m2,
  • who have not had an injection in the last two weeks in the area to be injected subcutaneously,
  • no signs of skin pain, hematoma, necrosis, scarring, incision or infection at the subcutaneous injection site,
  • patients treated with subcutaneous heparin injection therapy

You may not qualify if:

  • patients not receiving heparin injection therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Aydin University

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

PainAcute PainPersonal Satisfaction

Interventions

Vibration

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Mechanical PhenomenaPhysical Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All of the outcomes results were obtained by another researcher blinded to group allocation
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Prof.

Study Record Dates

First Submitted

December 30, 2022

First Posted

January 17, 2023

Study Start

September 20, 2022

Primary Completion

January 15, 2023

Study Completion

January 30, 2023

Last Updated

January 17, 2023

Record last verified: 2023-01

Locations